DiscoveRx introduces a novel NHR assay based on our core PathHunter™ assay platform. The assay utilizes a protein-protein interaction between the full-length NHR and a nuclear cofactor; which occurs prior to initiation of gene transcription. Unlike lengthy reporter gene assays the NHRPRO assay only requires ~ 6 hours. The technology is applicable to virtually all NHRs and is highly specific for the receptor of interest. Pharmacological data, technology information, and ordering information for validated targets are accessible using the links below. Please contact us for information about our custom assay development or NHR profiling services.
|
